Question 1

What is CBL-514?

Accepted Answer

CBL-514 is a novel, first-in-class small molecule injectable drug candidate that induces targeted adipocyte (fat cell) apoptosis, permanently eliminating fat cells without causing tissue necrosis or systemic inflammation.

Question 2

What is the purity of CBL-514 available here?

Accepted Answer

Each batch is analytically tested with High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to guarantee ≥98.0% chemical purity with verifiable Certificates of Analysis (COA).

Question 3

Is CBL-514 approved for human use?

Accepted Answer

No. CBL-514 is an investigational drug currently undergoing Phase 2 and Phase 3 clinical trials globally. Products offered on this site are strictly intended for laboratory and in-vitro scientific research.

adipocyte apoptosis research

CBL-514 Injection

We shape strategy & sculpt success